Technology

Axogen

$19.43
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$1.02 (+5.54%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Axogen and other stocks, options, and ETFs commission-free!

About AXGN

AxoGen, Inc. engages in the development and market of surgical solutions for peripheral nerves. It also provides products and education to improve surgical treatment algorithms for peripheral nerve damage or discontinuity. Its products include avance nerve graft, axoguard nerve connector, axoguard nerve protector, avive soft tissue membrane, acroval neurosensory and motor testing system, and axotouch two-point discriminator. The company was founded in 1977 and is headquartered in Alachua, FL. The listed name for AXGN is Axogen, Inc. Common Stock.

CEO
Karen L. Zaderej
Employees
394
Headquarters
Alachua, Florida
Founded
1977
Market Cap
789.22M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
296.66K
High Today
$19.62
Low Today
$18.35
Open Price
$18.50
Volume
381.47K
52 Week High
$20.83
52 Week Low
$7.16

Collections

AXGN Earnings

-$0.38
-$0.24
-$0.10
$0.04
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Feb 22, After Hours

You May Also Like

GLEO
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure